1. Home
  2. Labeler Index
  3. Wockhardt Limited
  4. 55648-738
  5. Product Images: Alfuzosin Hydrochloride

Product Images Alfuzosin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Alfuzosin Hydrochloride NDC 55648-738 by Wockhardt Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - alfuzosintablets m figure 01

Label - alfuzosintablets m figure 01

Each tablet contains 10mg of Alfuzosin hydrochloride, USP. The usual dosage can be found in the package insert. These are extended-release tablets that should be protected from light and moisture, dispensed in a tight and light-resistant container per the USP. They should be stored at room temperature and kept out of reach of children. The manufacturer is Wockhardt Limited, located in Mumbai, India.*

Label - alfuzosintablets m figure 02

Label - alfuzosintablets m figure 02

Each tablet of this drug contains 10 mg of Alfuzosin Hydrochloride, USP, which is used to treat symptoms of enlarged prostate in men. The usual dosage information is provided in the package insert. The drug should be protected from light and moisture, and stored at room temperature. This is a prescription medication and should be dispensed by a licensed pharmacist. The drug comes in a pack of 500 tablets and caution must be taken to keep it out of reach of children.*

Structure - alfuzosintablets m figure 03

Structure - alfuzosintablets m figure 03

Figure 1 - alfuzosintablets m figure 04

Figure 1 - alfuzosintablets m figure 04

Figure 2 - alfuzosintablets m figure 05

Figure 2 - alfuzosintablets m figure 05

Figure 3 - alfuzosintablets m figure 06

Figure 3 - alfuzosintablets m figure 06

Figure 4 - alfuzosintablets m figure 07

Figure 4 - alfuzosintablets m figure 07

Figure 5 - alfuzosintablets m figure 08

Figure 5 - alfuzosintablets m figure 08

Figure 6 - alfuzosintablets m figure 09

Figure 6 - alfuzosintablets m figure 09

This appears to be a list of two items, with the first item being "PLACEEO" and having a count of 147. The second item appears to be related to pharmaceuticals and references "Alfuzosin HCI extended-release tablets" with a count of 136.*

Figure 7 - alfuzosintablets m figure 10

Figure 7 - alfuzosintablets m figure 10

This text describes a clinical trial involving the use of a placebo (N=150) and Alluzosin HCl extended-release tablets (N=151). The text includes a graph tracking treatment progress over the course of 84 days, and it notes that there was no statistically significant difference between the two groups (NS p>0.08).*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.